POTS, Small Intestine Bacterial Overgrowth (SIBO) and Low Dose Naltrexone (LDN)

In this podcast episode, Dr. Leonard Weinstock, a gastroenterologist, discusses the gastrointestinal issues associated with syndromes such as POTS, EDS, and MCAS, focusing on small intestine bacterial overgrowth (SIBO) and the use of low dose naltrexone (LDN) as a treatment strategy. The discussion highlights the overlap between these conditions and gastrointestinal disorders, with an emphasis on addressing SIBO as a common comorbidity. Dr. Weinstock shares insights into effectively managing these complex conditions through targeted pharmacological treatments like LDN, which may help alleviate some of the associated symptoms.